Drug Information

Drug General Information
Drug ID
D07ODD
Former ID
DNC000522
Drug Name
DC-015
Drug Type
Small molecular drug
Indication Discovery agent Terminated [546169]
Structure
Download
2D MOL

3D MOL
Formula
C22H25N5O2
Canonical SMILES
COC1=CC=CC=C1N2CCN(CC2)CC3CN=C4N3C(=O)NC5=CC=CC=C54
InChI
1S/C22H25N5O2/c1-29-20-9-5-4-8-19(20)26-12-10-25(11-13-26)15-16-14-23-21-17-6-2-3-7-18(17)24-22(28)27(16)21/h2-9,16H,10-15H2,1H3,(H,24,28)
InChIKey
FUCGAUZSWYLMRK-UHFFFAOYSA-N
CAS Number
CAS 149847-87-0
PubChem Compound ID
5487531
PubChem Substance ID
11694173, 15450152, 39473182, 57364304, 78693830, 85221684, 103325937, 103960791, 113995224, 134222545, 134339929, 135087722, 162402166, 162794711, 233851129
Target and Pathway
Target(s) Alpha-1 adrenergic receptor Target Info Antagonist [535307]
References
Ref 546169Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006738)
Ref 535307Antihypertensive and Hypolipidemic Effects of DC-015, a Novel, Potent and Specific alpha(1)-Adrenoceptor Antagonist: Comparison with Prazosin in Spontaneously Hypertensive Rats. J Biomed Sci. 1996 Apr;3(2):108-116.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.